SEARCH

SEARCH BY CITATION

References

  • 1
    Field MJ, Lohr KN. Clinical practice guidelines: directions for a new program. Washington, DC: National Academy Press, 1990.
  • 2
    Hayward RS, Wilson MC, Tunis SR, Bass EB, Guyatt G. Users’ guides to the medical literature. VIII. How to use clinical practice guidelines. A. Are the recommendations valid? The Evidence-Based Medicine Working Group. JAMA 1995;274:570574.
  • 3
    Schünemann HJ, Fretheim A, Oxman AD. Improving the use of research evidence in guideline development: 13. Applicability, transferability and adaptation. Health Res Policy Syst 2006;4:25.
  • 4
    Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S et al. Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490.
  • 5
    Schünemann HJ, Vist GE, Jaeschke R, Kunz R, Cook DJ, Guyatt GH. Grading recommendations. In: GuyattGH, RennieD, MeadeMO, CookDJ, editors. Users’ guides to the medical literature: a manual for evidence-based clinical practice, 2nd edn. US: The McGraw-Hill Professional, 2008:679701.
  • 6
    Atkins D, Eccles M, Flottorp S, Guyatt GH, Henry D, Hill S et al. Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group. BMC Health Serv Res 2004;4:38.
  • 7
    Schünemann HJ, Jaeschke R, Cook DJ, Bria WF, El-Solh AA, Ernst A et al. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med 2006;174:605614.
  • 8
    Schünemann HJ, Best D, Vist G, Oxman AD. Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations. CMAJ 2003;169:677680.
  • 9
    Guyatt G, Vist G, Falck-Ytter Y, Kunz R, Magrini N, Schunemann H. An emerging consensus on grading recommendations? ACP J Club 2006;144:A8A9.
  • 10
    Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians task force. Chest 2006;129:174181.
  • 11
    BMJ Publishing Group Ltd. Article requirements. 2006 [cited 2008 February 11]; Available at: http://resources.bmj.com/bmj/authors/article-submission/article-requirements.
  • 12
    Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P et al. 12. Interpreting results and drawing conclusions [preliminary draft, 16 October 2007]. In: HigginsJPT, GreenS, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [Updated September 2008]. The Cochrane Collaboration, 2008. Available from http://www.cochrane-handbook.org.
  • 13
    The Endochrine Society. Evidence-based guidelines chart new course for endochrinology. Endochrine News, 2005;30:10.
  • 14
    Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296327.
  • 15
    UpToDate. Editorial Policy. 2006 [cited 2008 February 11]; Available at: http://www.uptodate.com/service/editorial_policy.asp.
  • 16
    World Health Organization. Guidelines for WHO guidelines [EIP/GPE/EQC/2003.1]Geneva, Switzerland: Global Programme on Evidence for Health Policy, WHO, 2003.
  • 17
    Brozek JL, Baena-Cagnani CE, Bonini S, Canonica GW, Rasi G, Van Wijk RG et al. Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update. Allergy 2008;63:3846.
  • 18
    Guyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A et al. Going from evidence to recommendations. BMJ 2008;336:10491051.
  • 19
    Guyatt GH, Oxman AD, Kunz R, Jaeschke R, Helfand M, Liberati A et al. Incorporating considerations of resources use into grading recommendations. BMJ 2008;336:11701173.
  • 20
    Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schunemann HJ. What is “quality of evidence” and why is it important to clinicians? BMJ 2008;336:995998.
  • 21
    Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924926.
  • 22
    Schünemann HJ, Oxman AD, Brozek J, Glasziou P, Jaeschke R, Vist GE et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ 2008;336:11061110.
  • 23
    Oxman AD, Guyatt GH. Guidelines for reading literature reviews. CMAJ 1988;138:697703.
  • 24
    Schünemann HJ, Hill SR, Kakad M, Vist GE, Bellamy R, Stockman L et al. Transparent development of the WHO rapid advice guidelines. PLoS Med 2007;4:e119.
  • 25
    Devereaux PJ, Anderson DR, Gardner MJ, Putnam W, Flowerdew GJ, Brownell BF et al. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. BMJ 2001;323:12181222.
  • 26
    Guyatt GH, Jaeschke R, Prasad K, Cook DJ. Summarizing the evidence. In: GuyattGH, RennieD, MeadeMO, CookDJ, editors. Users’ guides to the medical literature: a manual for evidence-based clinical practice, 2nd edn. US: The McGraw-Hill Professional, 2008:523542.
  • 27
    Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. JAMA 1992;268:240248.
  • 28
    David BA, MaryLou M, Brian M. A meta-analysis of the effect of oral and inhaled corticosteroids on growth. The Journal of allergy and clinical immunology 1994;93:967976.
  • 29
    Sharek PJ, Bergman DA, Ducharme F. Beclomethasone for asthma in children: effects on linear growth. Cochrane Database of Systematic Reviews 1999, Issue 3. Art. No.: CD001282. DOI: DOI: 10.1002/14651858.CD001282.
  • 30
    Campbell F, Gibson P. Feather versus non-feather bedding for asthma. Cochrane Database of Systematic Reviews 2000, Issue 4. Art. No.: CD002154. DOI: DOI: 10.1002/14651858.CD002154.
  • 31
    Butland BK, Strachan DP, Anderson HR. The home environment and asthma symptoms in childhood: two population based case-control studies 13 years apart. Thorax 1997;52:618624.
  • 32
    Guyatt GH, Straus S, Meade MO, Kunz R, Cook DJ, Devereaux PJ, et al.. Therapy. In: GuyattGH, RennieD, MeadeMO, CookDJ, editors. Users’ Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice. US: The McGraw-Hill Professional, 2008:6786.
  • 33
    Montori VM, Devereaux PJ, Adhikari NK, Burns KE, Eggert CH, Briel M et al. Randomized trials stopped early for benefit: a systematic review. JAMA 2005;294:22032209.
  • 34
    Chan AW, Altman DG. Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors. BMJ 2005;330:753.
  • 35
    Chan AW, Hrobjartsson A, Haahr MT, Gotzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 2004;291:24572465.
  • 36
    Chan AW, Krleza-Jeric K, Schmid I, Altman DG. Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. CMAJ 2004;171:735740.
  • 37
    Novembre E, Galli E, Landi F, Caffarelli C, Pifferi M, De Marco E et al. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 2004;114:851857.
  • 38
    Yorke J, Shuldham C. Family therapy for asthma in children. Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD000089. DOI: DOI: 10.1002/14651858.CD000089.pub2.
  • 39
    Montori V, Hatala R, Ioannidis JP, Meade MO, Wyer P, Guyatt GH. Advanced topics in systematic reviews. Making sense of variability in study results. In: GuyattGH, RennieD, MeadeMO, CookDJ, editors. Users’ guides to the medical literature: a manual for evidence-based clinical practice, 2nd edn. US: The McGraw-Hill Professional, 2008:563570.
  • 40
    Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557560.
  • 41
    Fletcher J. What is heterogeneity and is it important? BMJ 2007;334:9496.
  • 42
    Calderon M, Alves B, Jacobson M, Hurwitz B, Sheikh A, Durham S. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev 2007;1:CD001936.
  • 43
    Bassler D, Mitra A, Ducharme FM, Forster J, Schwarzer G. Ketotifen alone or as additional medication for long-term control of asthma and wheeze in children. Cochrane Database Syst Rev 2004;1:CD001384.
  • 44
    Wilson DR, Torres LI, Durham SR. Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev 2003;2:CD002893.
  • 45
    Mungan D, Misirligil Z, Gurbuz L. Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma – a placebo controlled study. Ann Allergy Asthma Immunol 1999;82:485490.
  • 46
    Quirino T, Iemoli E, Siciliani E, Parmiani S, Milazzo F. Sublingual versus injective immunotherapy in grass pollen allergic patients: a double blind (double dummy) study. Clin Exp Allergy 1996;26:12531261.
  • 47
    Mimouni Bloch A, Mimouni D, Mimouni M, Gdalevich M. Does breastfeeding protect against allergic rhinitis during childhood? A meta-analysis of prospective studies. Acta Paediatr 2002;91:275279.
  • 48
    Begg CB, Berlin JA. Publication bias and dissemination of clinical research. J Natl Cancer Inst 1989;81:107115.
  • 49
    Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Bmj 1997;315:629634.
  • 50
    Ioannidis JP. Why most published research findings are false. PLoS Med 2005;2:e124.
  • 51
    Owen CG, Shah A, Henshaw K, Smeeth L, Sheikh A. Topical treatments for seasonal allergic conjunctivitis: systematic review and meta-analysis of efficacy and effectiveness. Br J Gen Pract 2004;54:451456.
  • 52
    Sheikh A, Hurwitz B. House dust mite avoidance measures for perennial allergic rhinitis. Cochrane Database Syst Rev 2001;4:CD001563.
  • 53
    Bross ID. Pertinency of an extraneous variable. J Chronic Dis 1967;20:487495.
  • 54
    Glasziou P, Chalmers I, Rawlins M, McCulloch P. When are randomised trials unnecessary? Picking signal from noise. BMJ 2007;334:349351.
  • 55
    Devereaux PJ, Choi PT, Lacchetti C, Weaver B, Schunemann HJ, Haines T et al. A systematic review and meta-analysis of studies comparing mortality rates of private for-profit and private not-for-profit hospitals. CMAJ 2002;166:13991406.
  • 56
    Devereaux PJ, Schunemann HJ, Ravindran N, Bhandari M, Garg AX, Choi PT et al. Comparison of mortality between private for-profit and private not-for-profit hemodialysis centers: a systematic review and meta-analysis. JAMA 2002;288:24492457.
  • 57
    Salpeter S, Greyber E, Pasternak G, Salpeter E. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev 2006;1:CD002967.
  • 58
    Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH. Anti-IgE for chronic asthma in adults and children. Cochrane Database Syst Rev 2006;2:CD003559.
  • 59
    Fretheim A, Schünemann HJ, Oxman AD. Improving the use of research evidence in guideline development: 3. Group composition and consultation process. Health Res Policy Syst 2006;4:15.
  • 60
    Oxman AD, Schünemann HJ, Fretheim A. Improving the use of research evidence in guideline development: 2. Priority setting. Health Res Policy Syst 2006;4:14.